| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |